RxSight, Inc. RXST
Set alert
4.70 USD -0.10 -2.08%
As of Nov 3, 12:28 PM ET
4.64 Day range 4.78
4.40 52-week range 13.22
- YTD
- -54.89%
- 1 year
- -45.85%
- Open
- 4.78
- Prev close
- 4.80
- Mkt cap
- 195.07M
- Vol
- 275.98K
- Avg vol
- 776.44K
- EPS
- -1.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.64
- High
- 4.78
- Forward P/E
- -49.73
- Beta
- 1.22
- Short ratio
- 4.55
- Inst. own
- 91.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 7, 2024
- 50-d avg
- 29.42
- 200-d avg
- 43.84
- 1y target
- 41.90
Analyst view
Consensus: buy
Buy
Price target (mean) 41.90 +791.5% upside
Now 4.70
- Target (low)
- 28.00
- Target (mean)
- 41.90
- Target (high)
- 56.00
Ratings (0m) 10 8 buy · 2 hold · 0 sell
- Strong buy3
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.046 | -0.08 – 0.02 | -0.1195 | +61.5% | 39.80M | +34.9% | 5 |
| Next quarter | 0.00 | -0.03 – 0.03 | 0.0007 | -100.0% | 46.98M | +34.7% | 5 |
| Current year | -0.002 | -0.10 – 0.07 | -0.07 | +97.1% | 190.17M | +35.9% | 5 |
| Next year | 0.436 | 0.11 – 0.58 | -0.002 | +21900.0% | 237.51M | +24.9% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 21, 2025 | B of A Securities | Maintained | Buy | Buy |
| Mar 19, 2025 | Stifel | Maintained | Hold | Hold |
| Feb 26, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 26, 2025 | Stifel | Maintained | Hold | Hold |
| Feb 26, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 26, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 13, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 13, 2025 | Stifel | Maintained | Hold | Hold |
| Jan 13, 2025 | Needham | Reiterated | Buy | Buy |
| Dec 20, 2024 | Stifel | Downgrade | Buy | Hold |
| Dec 17, 2024 | Needham | Reiterated | Buy | Buy |
| Dec 11, 2024 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Dec 6, 2024 | UBS | Initiated | — | Buy |
| Oct 29, 2024 | Jefferies | Initiated | — | Buy |
| Sep 13, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 20, 2024 | Needham | Maintained | Buy | Buy |
| Aug 6, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 6, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 6, 2024 | Stifel | Maintained | Buy | Buy |
| Aug 6, 2024 | Needham | Maintained | Buy | Buy |
| Jul 15, 2024 | BTIG | Maintained | Buy | Buy |
| Jul 10, 2024 | Stifel | Maintained | Buy | Buy |
| May 7, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 7, 2024 | Needham | Maintained | Buy | Buy |
| May 7, 2024 | BTIG | Maintained | Buy | Buy |
| May 6, 2024 | Stifel | Maintained | Buy | Buy |
| Apr 11, 2024 | Needham | Reiterated | Buy | Buy |
| Feb 29, 2024 | Stifel | Maintained | Buy | Buy |
| Feb 29, 2024 | JP Morgan | Maintained | Overweight | Overweight |